Article

Percutaneous transcatheter closure of the aortic valve to treat cardiogenic shock in a left ventricular assist device patient with severe aortic insufficiency.

Section of Cardiac and Thoracic Surgery, Department of Surgery, University of Chicago Medical Center, Chicago, Illinois 60637, USA.
The Annals of thoracic surgery (impact factor: 3.74). 09/2012; 94(3):985-8. DOI:10.1016/j.athoracsur.2012.01.089 pp.985-8
Source: PubMed

ABSTRACT In this case report, we present a patient status post left ventricular assist device implantation complicated by de novo aortic insufficiency. At 8 months postimplant, the patient underwent a reoperative aortic valve repair, without complete closure of the valve. Three months after reoperation, the patient developed cardiogenic shock secondary to recurrent, severe aortic insufficiency. Ultimately, the patient underwent percutaneous, transcatheter closure of the aortic valve with an Amplatzer Cribiform device (AGA Medical Corp, Plymouth, MN). Two months post procedure, the patient remains stable with improved symptoms and functional status, and without evidence of further aortic insufficiency or device migration.

0 0
 · 
0 Bookmarks
 · 
17 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

Amplatzer Cribiform device
 
aortic insufficiency
 
aortic valve
 
cardiogenic shock secondary
 
case report
 
complete closure
 
de novo aortic insufficiency
 
device implantation
 
device migration
 
months post procedure
 
patient status post
 
percutaneous
 
Plymouth
 
reoperative aortic valve
 
severe aortic insufficiency
 
symptoms
 
transcatheter closure
 
ventricular